Literature DB >> 22259208

Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China.

Xiaobing Zhang1, Bing Zhao, Liguo Liu, Yafang Zhu, Yanlin Zhao, Qi Jin.   

Abstract

The presence of heteroresistance was represented by 23% of 235 fluoroquinolone (FQ)-resistant Mycobacterium tuberculosis isolates in Beijing, China, from 2008 to 2010. The main mechanism of FQ heteroresistance is due to the segregation of a single M. tuberculosis strain in patients; the majority of isolates with multidrug-resistant tuberculosis contained a mixture of bacterial subpopulations consisting of various mutant types, suggesting that the improper use of FQ is the major cause of FQ resistance.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22259208      PMCID： PMC3318552          DOI： 10.1128/JCM.05793-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.

Authors:  A Laszlo; M Rahman; M Raviglione; F Bustreo
Journal:  Int J Tuberc Lung Dis       Date:  1997-06       Impact factor: 2.373

2.  Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis.

Authors:  Philip Supply; Caroline Allix; Sarah Lesjean; Mara Cardoso-Oelemann; Sabine Rüsch-Gerdes; Eve Willery; Evgueni Savine; Petra de Haas; Henk van Deutekom; Solvig Roring; Pablo Bifani; Natalia Kurepina; Barry Kreiswirth; Christophe Sola; Nalin Rastogi; Vincent Vatin; Maria Cristina Gutierrez; Maryse Fauville; Stefan Niemann; Robin Skuce; Kristin Kremer; Camille Locht; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

3.  Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.

Authors:  S Hofmann-Thiel; J van Ingen; K Feldmann; L Turaev; G T Uzakova; G Murmusaeva; D van Soolingen; H Hoffmann
Journal:  Eur Respir J       Date:  2008-10-01       Impact factor: 16.671

4.  Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.

Authors:  T Kocagöz; C J Hackbarth; I Unsal; E Y Rosenberg; H Nikaido; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

5.  Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.

Authors:  I Guillemin; V Jarlier; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

6.  Heteroresistance to penicillin in Streptococcus pneumoniae.

Authors:  Brigitte Morand; Kathrin Mühlemann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-17       Impact factor: 11.205

7.  Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China.

Authors:  Peng Xu; Xia Li; Ming Zhao; Xiaohong Gui; Kathryn DeRiemer; Sebastien Gagneux; Jian Mei; Qian Gao
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

8.  Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.

Authors:  Duy An Duong; Thi Hong Duyen Nguyen; Thi Ngoc Lan Nguyen; Viet Hoa Dai; Thi Minh Ha Dang; Sy Kiet Vo; Dang Anh Thu Do; Van Vinh Chau Nguyen; Huy Dung Nguyen; Ngoc Sy Dinh; Jeremy Farrar; Maxine Caws
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

9.  Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay.

Authors:  Soumitesh Chakravorty; Bola Aladegbami; Kimberley Thoms; Jong Seok Lee; Eun Gae Lee; Vignesh Rajan; Eun-Jin Cho; Hyunchul Kim; Hyunkyung Kwak; Natalia Kurepina; Sang-Nae Cho; Barry Kreiswirth; Laura E Via; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

10.  Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation.

Authors:  Vladyslav Nikolayevskyy; Yanina Balabanova; Tatyana Simak; Nadezhda Malomanova; Ivan Fedorin; Francis Drobniewski
Journal:  BMC Clin Pathol       Date:  2009-03-10
View more
  16 in total

1.  High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.

Authors:  Brandon Eilertson; Fernanda Maruri; Amondrea Blackman; Miguel Herrera; David C Samuels; Timothy R Sterling
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?

Authors:  Jim Werngren; Erik Alm; Mikael Mansjö
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

3.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

4.  Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay.

Authors:  Bin Liang; Yaoju Tan; Zi Li; Xueshan Tian; Chen Du; Hui Li; Guoli Li; Xiangyang Yao; Zhongan Wang; Ye Xu; Qingge Li
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

5.  Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors.

Authors:  Hillary N Bengtson; Susanne Homolka; Stefan Niemann; Ana Júlia Reis; Pedro Eduardo da Silva; Yulia V Gerasimova; Dmitry M Kolpashchikov; Kyle H Rohde
Journal:  Biosens Bioelectron       Date:  2017-03-01       Impact factor: 10.618

6.  Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.

Authors:  Yuan Cao; Heta Parmar; David Alland; Soumitesh Chakravorty; Rajiv L Gaur; Deanna Lieu; Shobana Raghunath; Nova Via; Simone Battaglia; Daniela M Cirillo; Claudia Denkinger; Sophia Georghiou; Robert Kwiatkowski; David Persing
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

7.  Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.

Authors:  Xiaobing Zhang; Liguo Liu; Yan Zhang; Guangming Dai; Hairong Huang; Qi Jin
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

8.  Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.

Authors:  Qingyun Liu; Tao Luo; Jing Li; Jian Mei; Qian Gao
Journal:  J Antimicrob Chemother       Date:  2013-01-03       Impact factor: 5.790

9.  Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing.

Authors:  Rebecca E Colman; James M Schupp; Nathan D Hicks; David E Smith; Jordan L Buchhagen; Faramarz Valafar; Valeriu Crudu; Elena Romancenco; Ecaterina Noroc; Lynn Jackson; Donald G Catanzaro; Timothy C Rodwell; Antonino Catanzaro; Paul Keim; David M Engelthaler
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

10.  Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis.

Authors:  Suporn Pholwat; Suzanne Stroup; Suporn Foongladda; Eric Houpt
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.